Highly Efficient Ex Vivo Correction of COL7A1 through Ribonucleoprotein-Based CRISPR/Cas9 and Homology-Directed Repair to Treat Recessive Dystrophic Epidermolysis Bullosa.

Berthault C, Gaucher S, Gouin O, Schmitt A, Chen M, Woodley D, Titeux M, Hovnanian A, Izmiryan A
J Invest Dermatol. 2023 Dec 1:S0022-202X(23)03117-2. doi: 10.1016/j.jid.2023.10.035. PubMed Article

Plasmids from Article

No plasmids are currently publicly available from Addgene for this article.